Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks : a prospective, open-label, randomized controlled trial
Latest Information Update: 31 Oct 2019
At a glance
- Drugs Lamivudine/abacavir (Primary) ; Lopinavir/ritonavir (Primary) ; Lamivudine; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 31 Oct 2019 New trial record